Chronic Obstructive Pulmonary Disease (COPD). Chronic obstructive pulmonary disease, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Oral syrup,compound "Ma-ol-asal Syrup contains honey, ginger, cinnamon, cardamom, saffron, Alpinia officinarum, oral syrup (250ml),10 ml three times a day,for 8 we
Sponsors
Bagheiat-allah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients with COPD referring to the lung clinic People who are willing to participate in the study.
Exclusion criteria
Exclusion criteria: Very severe COPD require hospitalization Underlying illnesses, such as CF, Broncho-pulmonary dysplasia, heart failure, broncho-tracheomalacia, bronchiectasis, pulmonary embolism and sarcoidosis. Taking drugs such as aspirin, beta-blocker and NSAID. Allergic to any of the components of "Ma-ol-asal"
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms. Timepoint: At the beginning of the study (before the intervention) and 8 weeks after commencing consumption of the compound syrup. Method of measurement: CAT questionnaire.;Quality of life. Timepoint: At the beginning of the study (before the intervention) and 8 weeks after commencing consumption of the compound syrup. Method of measurement: The St George's respiratory questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Respiratory test changes in FEV1, FEV1 / FVC. Timepoint: At the beginning of the study (before the intervention) and 8 weeks after commencement of the administration of the compound syrup. Method of measurement: Pulmonary functional test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZohreh Poursaleh
Shahid Beheshti University of Medical Sciences
Outcome results
None listed